Reset-RA - See if you qualify for the study (3.0 live)

The next question is about your medication history with the following drugs:

Conventional DMARDs
- Arava (leflunomide)
- Azulfidine (sulfasalazine)
- Hydroxychloroquine (oral tablet)
- Leflunomide (oral tablet)
- Methotrexate LPF sodium (injection)
- Methotrexate (generic) (oral tablet)
- Otrexup (methotrexate injection)
- Plaquenil (hydroxychloroquine)
- Rasuvo (methotrexate injection)
- Rheumatrex (methotrexate oral tablet)
- Sulfasalazine (oral tablet)
- Trexall (methotrexate oral tablet)
ARE YOU CURRENTLY TAKING ANY OF CONVENTIONAL DMARDS LISTED ABOVE TO TREAT YOUR RHEUMATOID ARTHRITIS?*

YesNo
The next question is about your medication history with the following drugs:

Biologic DMARDs (Biologics)
- Actemra (tociluzumab) (infusion)
- Cimzia (certolizumab pegol) (self-injection)
- Enbrel (etanercept) (self-injection)
- Humira (adalimumab) (self-injection)
- Kevzara (sarilumab) (injection)
- Kineret (anakinra) (injection)
- Orencia (abatacept) (infusion or self-injection)
- Remicade (infliximab) (infusion)
- Rituxan (rituximab) (infusion)
- Simponi (golimumab) (self-injection)
- Simponi Aria (golimumab) (infusion)
HAVE YOU EVER TAKEN ANY OF THE BIOLOGICS LISTED ABOVE TO TREAT YOUR RHEUMATOID ARTHRITIS?*

YesNo
The next two questions are about your medication history with the following drugs:

Targeted Synthetic DMARDs (JAKs)
- Olumiant (baricitinib) (oral tablet)
- Rinvoq (upadacitinib) (oral tablet)
- Xeljanz (tofacitinib) (oral tablet)
- Xeljanz XR (tofacitinib) (oral tablet)
HAVE YOU EVER TAKEN ANY OF THE JAKs LISTED ABOVE TO TREAT YOUR RHEUMATOID ARTHRITIS?*

YesNo

Great, thank you! Based on your responses, you may qualify for participation in the RESET-RA study.

Please read and acknowledge the disclosure below related to our privacy policy to give us permission to collect your contact information and have a health-care professional contact you to discuss this study.
I acknowledge the RESET-RA website privacy policy and consent to be contacted about my potential participation in the study. I hereby agree to provide the call center personnel my name and other relevant information to further evaluate my eligibility for this study. I understand that my contact information will be shared with a RESET-RA clinical study site if I am deemed eligible for the study.*

Yes

Our health-care professionals are available Monday through Friday between 8 AM and 8 PM Eastern Time from Monday through Friday. When should they call you?

(All times below are Eastern.)
Appointment

Please provide us with the following information so that a health-care professional can contact you.
Name*

First NameLast Name
Phone Number*

Area CodePhone Number
Email*
example@example.com
Zip Code
Text Reminder
SMS Reminder Email
example@example.com
Appointment Email Reminder Time
Please submit your survey answers to see if you meet the initial criteria for the study.
Should be Empty: